|
Dear All, The Council of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has approved an updated Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases. This extends the range of clinical trials that member companies should provide information on to include all clinical trials in patients, as a minimum. The scope of this new Joint Position will include early stage safety trials of medicines for life-threatening conditions, which are typically not done in healthy volunteers. For the press release click here. Best regards |
IP Logged
|
Last Edited On: 2009-11-20 17:55:53 By GCP HelpDesk for the Reason |
GCP HelpDesk |